JW (Cayman) Therapeutics Co. Ltd (2126.HK)
HKD 1.3
(0.0%)
HKD 1.3
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -687.11 Million CNY | 37.77% |
| 2022 | -1.1 Billion CNY | 34.56% |
| 2021 | -1.68 Billion CNY | 32.69% |
| 2020 | -2.5 Billion CNY | -1315.72% |
| 2019 | -177.08 Million CNY | -136.2% |
| 2018 | -74.97 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -535.43 Million CNY | 0.0% |
| 2023 Q2 | -951.79 Million CNY | 0.0% |
| 2023 Q4 | -687.11 Million CNY | 0.0% |
| 2023 FY | -687.11 Million CNY | 37.77% |
| 2022 FY | -1.1 Billion CNY | 34.56% |
| 2022 Q4 | -1.23 Billion CNY | 0.0% |
| 2022 Q2 | -1.6 Billion CNY | 0.0% |
| 2021 Q4 | -2.06 Billion CNY | 0.0% |
| 2021 Q2 | -2.5 Billion CNY | 0.0% |
| 2021 FY | -1.68 Billion CNY | 32.69% |
| 2020 FY | -2.5 Billion CNY | -1315.72% |
| 2020 Q4 | -2.97 Billion CNY | 0.0% |
| 2020 Q2 | 2.07 Billion CNY | 0.0% |
| 2019 Q4 | 1.38 Billion CNY | 0.0% |
| 2019 FY | -177.08 Million CNY | -136.2% |
| 2019 Q2 | - HKD | 0.0% |
| 2018 FY | -74.97 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | -76.36 Million HKD | -799.729% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 113.046% |